Matching articles for "Flolipid"
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • September 19, 2022; (Issue 1659)
...
View the Comparison Table: Some Lipid-Lowering Drugs
Bempedoic Acid (Nexletol) for Lowering LDL-Cholesterol
The Medical Letter on Drugs and Therapeutics • April 6, 2020; (Issue 1595)
The FDA has approved the oral adenosine triphosphate-citrate
lyase (ACL) inhibitor bempedoic acid for
use alone (Nexletol – Esperion) and in a fixed-dose
combination with the cholesterol absorption...
The FDA has approved the oral adenosine triphosphate-citrate
lyase (ACL) inhibitor bempedoic acid for
use alone (Nexletol – Esperion) and in a fixed-dose
combination with the cholesterol absorption inhibitor
ezetimibe (Nexlizet) as an adjunct to diet and maximally
tolerated statin therapy in adults with heterozygous
familial hypercholesterolemia (HeFH) or established
atherosclerotic cardiovascular disease (ASCVD) who
require additional lowering of LDL-cholesterol (LDL-C).
Bempedoic acid is the first ACL inhibitor to be approved
in the US.
Expanded Table: Statins (online only)
The Medical Letter on Drugs and Therapeutics • September 23, 2019; (Issue 1581)
...
View the Expanded Table: Statins
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • February 11, 2019; (Issue 1565)
Cholesterol management guidelines from the American
College of Cardiology/American Heart Association Task
Force have recently been published. See Table 1 for a
brief summary of their...
Cholesterol management guidelines from the American
College of Cardiology/American Heart Association Task
Force have recently been published. See Table 1 for a
brief summary of their recommendations.
Expanded Table: Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • February 11, 2019; (Issue 1565)
...
View the Expanded Table: Lipid-Lowering Drugs